Inflammatory Disease Biotech Evommune Sets Terms for $150 Million IPO
Evommune, a clinical-stage biotechnology company developing therapies for chronic inflammatory diseases, has officially announced the terms for its $150 million initial public offering. The...
UK Social Commerce Firm WeShop Sets November 10 for Unique Nasdaq Direct Listing
WeShop Holdings, a UK-based social commerce platform with a unique model that rewards shoppers with company equity, has officially set its market debut for...
Omeed Malik Files for Third “American Exceptionalism” SPAC, Targeting $260 Million IPO
Colombier Acquisition III, the third blank check company led by financier Omeed Malik, filed on Friday for a $260 million initial public offering. This...
Faith-Tech Platform Gloo Holdings Files for $100 Million IPO to Digitize Churches
Gloo Holdings, a technology company that provides management and marketing platforms for faith-based organizations, filed on Friday for a $100 million initial public offering....
Hong Kong Services Firm Acco Group Debuts on Nasdaq After Pricing $6 Million IPO at $4
Acco Group Holdings, a Hong Kong-based provider of corporate secretarial and accounting services, completed its market debut on the Nasdaq, raising $6 million after...